currency hit Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device launches and growing demand for its glucose monitors to ...
Hosted on MSN1mon
Abbott Laboratories (NYSE:ABT) Posts Q4 Sales In Line With EstimatesHealthcare product and device company Abbott Laboratories (NYSE:ABT) in Q4 CY2024, with sales up 7.2% year on year to $10.97 billion. Its non-GAAP profit of $1.34 per share was in line with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback